ABUS

NASDAQStock

Arbutus Biopharma Corporation

$4.25-0.07 (-1.50%)

52-Week Range

$2.88
$4.95

Key Stats

Market Cap

818.3M

P/E Ratio

Dividend Yield

Beta

0.74

Volume

1.2M

Avg Volume

3.3M

Performance

1M

+7.73%

3M

-12.73%

6M

-4.64%

YTD

-9.43%

1Y

+30.91%

3Y

+42.57%

5Y

+14.29%

Price Chart

ETF Exposure

ABUS is held by 93 ETFs

ETFFund NameWeight
SMMDiShares Russell 2500 ETF0.01%
SPGMState Street SPDR Portfolio MSCI Global Stock Market ETF0.01%
WSML.LiShares MSCI World Small Cap UCITS ETF0.01%
WDSC.LState Street SPDR MSCI World Small Cap UCITS ETF (Acc)0.00%
WOSC.LState Street SPDR MSCI World Small Cap UCITS ETF (Acc)0.00%
ZPRS.DEState Street SPDR MSCI World Small Cap UCITS ETF (Acc)0.00%
HDGProShares - Hedge Replication ETF0.00%
IWNiShares Russell 2000 Value ETF0.00%
VALTETFMG Sit Ultra Short ETF0.00%
SILXETFMG Prime 2x Daily Junior Silver Miners ETF0.00%
USFM.LUBS MSCI USA Select Factor Mix UCITS ETF USD dis0.00%
VTWVVanguard Russell 2000 Value ETF0.00%
EAOAiShares ESG Aware 80/20 Aggressive Allocation ETF0.00%
EAOKiShares ESG Aware 30/70 Conservative Allocation ETF0.00%
EAOMiShares ESG Aware 40/60 Moderate Allocation ETF0.00%
EAORiShares ESG Aware 60/40 Balanced Allocation ETF0.00%
ITOTiShares Core S&P Total U.S. Stock Market ETF0.00%
IWViShares Russell 3000 ETF0.00%
SCHBSchwab U.S. Broad Market ETF0.00%
VTHRVanguard Russell 3000 ETF0.00%
VTIVanguard Total Stock Market ETF0.00%
VUN.TOVanguard U.S. Total Market Index ETF0.00%
VUS.TOVanguard U.S. Total Market Index ETF (CAD-hedged)0.00%
XEQT.TOiShares Core Equity ETF Portfolio0.00%
XUU.TOiShares Core S&P U.S. Total Market Index ETF0.00%
ZPRV.DEState Street SPDR MSCI USA Small Cap Value Weighted UCITS ETF0.00%
ITDBiShares LifePath Target Date 2030 ETF0.00%
ITDCiShares LifePath Target Date 2035 ETF0.00%
ITDDiShares LifePath Target Date 2040 ETF0.00%
ITDEiShares LifePath Target Date 2045 ETF0.00%
ITDFiShares LifePath Target Date 2050 ETF0.00%
ITDGiShares LifePath Target Date 2055 ETF0.00%
ITDHiShares LifePath Target Date 2060 ETF0.00%
ITDIiShares LifePath Target Date 2065 ETF0.00%
ITDJiShares LifePath Target Date 2070 ETF0.00%
LSLTPacer Salt Low truBeta US Market ETF0.00%
SLTPacer Salt High truBeta US Market ETF0.00%
TRPLPacer Metaurus US Large Cap Dividend Multiplier 300 ETF0.00%
VCNS.TOVanguard Conservative ETF Portfolio0.00%
VEQT.TOVanguard All-Equity ETF Portfolio0.00%
VETSPacer Military Times Best Employers ETF0.00%
VIRSPacer BioThreat Strategy ETF0.00%
VRIF.TOVanguard Retirement Income ETF Portfolio0.00%
PreviousPage 2 of 2

About ABUS ETF Exposure

Arbutus Biopharma Corporation (ABUS) is held by 93 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 818.3M, ABUS is a widely held institutional stock. The stock currently trades at $4.25. Investors can gain exposure to ABUS through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold ABUS, sorted by portfolio weight.